From: Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
Risk groupsa | Â | Patientsb | Distribution (%)c |
---|---|---|---|
INSS stage | 1 | 42 | 23,1 |
 | 2 | 24 | 13,2 |
 | 3 | 23 | 12,6 |
 | 4 | 70 | 37,9 |
 | 4s | 23 | 13,2 |
Age at diagnosis | < = 1 year | 92 | 51,1 |
 | > 1 year | 90 | 48,9 |
MYCN status | Normal | 153 | 84,1 |
 | Amplified | 29 | 15,9 |
5 years survival | Dead | 55 | 29,7 |
 | Alive | 127 | 70,3 |